InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the detailed record of transactions filed by Von Seggern Christopher, Directeur commercial. Director active across 1 company, notably Xenon Pharmaceuticals Inc.. Aggregated, 1 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €86k. Activity tracked since 6 December 2021. The latest transaction was filed on 6 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Christopher Von Seggern is the Chief Commercial Officer at Xenon Pharmaceuticals Inc. He is responsible for the company's commercial strategy, overseeing sales and marketing initiatives. His expertise contributes to the company's growth and market visibility.